Back

Levosimendan prevents and reverts pressure-overload induced right ventricular failure.

29 August 2016 (10:40 - 10:47)
Organised by:
Congress Presentation Part of: Basic mechanisms in pulmonary hypertension Right ventricular function ESC Premium Access ESC Congress 2016

About the speaker

Photo
Miss Mona Sahlholdt Hansen

Aarhus University Hospital, Aarhus (Denmark)

6 More presentations in this session

Presentation thumbnail
A new experimental model of pulmonary arterial hypertension- KDR knock out
Doctor M. Winter (Vienna, AT)
Abstract Slides
Presentation thumbnail
Hypoxia induces the downregulation of the BMP signalling in pulmonary artery smooth muscle cells through the endothelin system
Doctor H. Maruyama (Tsuchiura, JP)
Abstract Slides
Presentation thumbnail
Preventive effects of novel urotensin II receptor antagonist in experimental pulmonary arterial hypertension
Doctor B. Lee (Daejeon, KR)
Abstract Slides
Presentation thumbnail
Hemodynamic and anti-remodelling effect of the rho kinase inhibitor y-27632 in monocrotaline pulmonary arterial hypertension rat model
Doctor S. Cantoni (Parma, IT)
Abstract Slides
Presentation thumbnail
Hypoxia-induced pulmonary hypertension is attenuated by hypoxia-inducible factor-1 alpha deletion in macrophage
Mr H. Kojima (Fukuoka, JP)
Abstract Slides

Access the full session

Session thumbnail
Basic mechanisms in pulmonary hypertension

The Event

Event poster

ESC Congress 2016

29 August 2016 10:40 CET
You may be interested in
thumbnail
Congress Presentation
Insights from the contemporary use of levosimendan in a tertiary cardiology centre
20 May 2023
thumbnail
Congress Presentation
Right ventricular diastolic adaptation to pressure overload in different rat strains
25 August 2023
thumbnail
Webinar
Focus on percutaneous short-term ventricular assist devices: joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices - Part 3. PVAD in right and biventricular failure
8 March 2022
thumbnail
Congress Presentation
Overlays and discrepancies of load-dependent and load-independent right ventricular systolic function and the potential for functional recovery after load-modifying therapies
22 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources